Compare · ELV vs HHLA
ELV vs HHLA
Side-by-side comparison of Elevance Health Inc. (ELV) and HH&L Acquisition Co. (HHLA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and HHLA operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $90.81B, about 181.3x HHLA ($500.9M).
- ELV has hit the wire 3 times in the past 4 weeks while HHLA has been quiet.
- ELV has more recent analyst coverage (23 ratings vs 0 for HHLA).
- Company
- Elevance Health Inc.
- HH&L Acquisition Co.
- Price
- $418.31+0.63%
- $10.76+0.09%
- Market cap
- $90.81B
- $500.9M
- 1M return
- +12.19%
- -
- 1Y return
- +7.35%
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 3
- 0
- Recent ratings
- 23
- 0
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
HH&L Acquisition Co.
HH&L Acquisition Co. is a blank check company. HH&L Acquisition Co. was incorporated in 2020 and is based in Central, Hong Kong.
Latest ELV
- Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
- CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)
- Elevance Health upgraded by Deutsche Bank with a new price target
- Director Schulman Amy W was granted 563 shares, increasing direct ownership by 258% to 781 units (SEC Form 4)
- Director Schneider Ryan M. was granted 563 shares, increasing direct ownership by 9% to 7,163 units (SEC Form 4)
- Director Peru Ramiro G was granted 563 shares, increasing direct ownership by 6% to 9,908 units (SEC Form 4)
- Director Neri Antonio F was granted 563 shares, increasing direct ownership by 11% to 5,488 units (SEC Form 4)
- Director Jallal Bahija was granted 563 shares, increasing direct ownership by 12% to 5,351 units (SEC Form 4)
- Director Hay Lewis Iii was granted 563 shares, increasing direct ownership by 5% to 12,070 units (SEC Form 4)
- Director Dixon Robert L Jr was granted 563 shares, increasing direct ownership by 5% to 10,885 units (SEC Form 4)
Latest HHLA
- SEC Form 25-NSE filed by HH&L Acquisition Co.
- SEC Form SC 13G filed by HH&L Acquisition Co.
- SEC Form SC 13G filed by HH&L Acquisition Co.
- SEC Form SC 13G/A filed by HH&L Acquisition Co. (Amendment)
- SEC Form SC 13G filed by HH&L Acquisition Co.
- SEC Form SC 13G filed by HH&L Acquisition Co.
- SEC Form SC 13G/A filed by HH&L Acquisition Co. (Amendment)
- SEC Form SC 13G/A filed by HH&L Acquisition Co. (Amendment)
- HH&L Acquisition Co. Shares Halted Under Code News Pending
- HH&L Acquisition Co Decides That It Will Redeem All Of Its Outstanding Ordinary Shares That Were Included In Units Issued In Its IPO; Per-Share Redemption Price For Public Shares Will Be About $10.79, Before Payment Of Taxes And Dissolution Expenses